Emergence Therapeutics
ID: 9539184Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.
2
Funding Rounds
$191.3m
Money raised
Recent Funding Rounds
Overview
Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.
- Website:
- Business model: B2B
- Headquarters: Duisburg
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company Emergence Therapeutics has raised a total of $191.3m in funding over 2 rounds.
Key Insights:
- Emergence Therapeutics Series A round, December 2021: $92.3m
- Emergence Therapeutics December 2021 Funding Round: $99m
Industries
Emergence Therapeutics is active in the following industries: